Citius Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Citius Pharmaceuticals, Inc. (CTXR) had Deferred Tax Assets, Operating Loss Carryforwards of $48.99 million as of 2025-09-30, per its 10-K filed 2025-12-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-12-23
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards $48.99M.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards $39.89M.
- 2023-09-30: Deferred Tax Assets, Operating Loss Carryforwards $34.98M.
- 2022-09-30: Deferred Tax Assets, Operating Loss Carryforwards $34.67M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-09-30 | $48.99M 10-K · filed 2025-12-23 |
| 2024-09-30 | $39.89M 10-K · filed 2025-12-23 |
| 2023-09-30 | $34.98M 10-K · filed 2024-12-27 |
| 2022-09-30 | $34.67M 10-K · filed 2023-12-29 |
| 2021-09-30 | $25.51M 10-K · filed 2022-12-22 |
| 2020-09-30 | $14.50M 10-K · filed 2021-12-15 |
| 2019-09-30 | $10.99M 10-K · filed 2020-12-16 |
| 2018-09-30 | $8.96M 10-K · filed 2019-12-16 |
| 2017-09-30 | $7.12M 10-K · filed 2018-12-11 |
| 2016-09-30 | $3.80M 10-K · filed 2017-12-13 |
| 2015-09-30 | $1.13M 10-K · filed 2016-12-23 |
| 2014-09-30 | $27.00K 10-K · filed 2015-12-14 |
| 2013-09-30 | $95.22K 10-K · filed 2014-02-06 |
| 2012-09-30 | $63.85K 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |